<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141378">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02072083</url>
  </required_header>
  <id_info>
    <org_study_id>2013/381</org_study_id>
    <nct_id>NCT02072083</nct_id>
  </id_info>
  <brief_title>Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric Patients</brief_title>
  <official_title>Intranasal Dexmedetomidine Versus Intranasal Midazolam-ketamine Combination for Premedication of Pediatric Patients Undergoing Strabismus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is using intranasal dexmedetomidine versus intranasal
      midazolam-ketamine combination for premedication and preventing the oculocardiac reflex of
      pediatric patients undergoing strabismus surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preanesthetic medication in pediatrics is very helpful in relieving anxiety, fear and
      psychological trauma due to maternal deprivation. Midazolam and ketamine are commonly used
      for this purpose. Dexmedetomidine is an alpha 2 -agonist with a more selective action on the
      alpha 2 adrenoreceptor when administered via the nasal mucosa bioavailability of
      dexmedetomidine is too high. Intranasal route is an effective way to administer
      premedication and sedation to children. The oculocardiac reflex is a major complication of
      pediatric strabismus surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>the efficacy of premedication on ramsey sedation score</measure>
    <time_frame>30 min after premedication</time_frame>
    <safety_issue>No</safety_issue>
    <description>after drug administration ramsey sedation scale is evaluate every 5 min.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the effects of premedication on oculocardiac reflex</measure>
    <time_frame>during the surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>the heart rate drops the 20% of the resting rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mask acceptance scale</measure>
    <time_frame>30 min after sedation</time_frame>
    <safety_issue>No</safety_issue>
    <description>The subject's ability to accept the anesthesia mask is measured using the mask acceptance scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the parenteral separation anxiety scale</measure>
    <time_frame>30 min after sedation</time_frame>
    <safety_issue>No</safety_issue>
    <description>The response to the child parent separation is assessed and graded according to a 4 point scale at 30 min.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Premedication</condition>
  <condition>Oculocardiac Reflex</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intranasal 1mcg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ketamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intranasal 7,5 mg/kg ketamine  and 0,1 mg/kg midazolam</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>via intranasal route 1 mcg/kg</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>via intranasal route 7,5 mg/kg ketamine and 0,1 mg/kg midazolam</description>
    <arm_group_label>ketamine</arm_group_label>
    <other_name>ketalar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  the pediatric patients undergoing strabismus surgery

          -  the pediatric patients between 2-11 years old

          -  ASA physical status I-II

          -  the patients whose parents give permission for this study

        Exclusion Criteria:

          -  a known drud allergy or hypersensitive reaction to drugs used

          -  mental retardation

          -  cardiac arrhythmia or congenital cardiac disease

          -  organ disfunction (liver , kidney)

          -  nasal pathology

          -  psychotropic  treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Müge Yüce Yıldırım, resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>erciyes universty</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Müge Yüce Yıldırım, Resident</last_name>
    <phone>+905309220516</phone>
    <email>mugeyy@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adem Boyacı, Proff.</last_name>
    <phone>+905322434478</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erciyes university hospital</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Müge Yüce Yıldırım, resident</last_name>
      <phone>+905309220516</phone>
      <email>mugeyy@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 26, 2014</lastchanged_date>
  <firstreceived_date>February 15, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>müge yüce yıldırım</investigator_full_name>
    <investigator_title>resident</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>intranasal</keyword>
  <keyword>strabismus surgery</keyword>
  <keyword>premedication</keyword>
  <keyword>oculocardiac reflex</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
